EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Companies

CGenetix

Pépinière Genopole, 4 rue Pierre Fontaine
91000 Evry-Courcouronnes

Geoffroy POULET: CEO
Contact: geoffroy.poulet@cgenetix.com
Site Web >
CGenetix - Entreprise génopolitaine CGenetix - Entreprise génopolitaine

Shaker#health and well-being #diagnostics #medical devices

  • Kidney transplant
  • Circulating DNA
  • Digital PCRLogo Gene.iO small
  • Precision analysis

Field of activity

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

BACKGROUND

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Class C in vitro diagnostic tests to quantify organ lesions via a blood sample. CGenetix’s test is based on the analysis of molecular signatures present in the circulating DNA released by transplanted kidneys during immune rejection.

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS

  • Clinical partnership with the renal transplant departments of the Necker and Tenon Hospitals (AP-HP) in July 2022.
  • Clinical partnership with the nephrology departments of the Bicêtres Hospital and South Île-de-France Medical Center.

COLLABORATIONS SOUGHT

  • Partnerships with pharmaceutical companies developing graft-rejection-limiting treatments.
  • Partnerships with solid-organ-transplantation reference hospitals (kidney and/or other).
  • Further information

    1 patent

    Strengths:
    Dynamic, multidisciplinary team, a clear company vision, quickly growing market

    Innovation assets:
    Rapid, affordable, ultra-sensitive, ultra-specific, non-invasive technology.

Share
Genopole’s Companies

#Diagnostics

In the same field

EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
SafeInsight - Entreprise génopolitaine

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Enalees - Genopole Company 2024

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news